Precision BioSciences, Inc.

NasdaqCM:DTIL Stock Report

Market Cap: US$211.1m

Precision BioSciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:DTIL Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Dec 25BuyUS$12,690Stanley FrankelIndividual2,700US$4.70
16 Dec 25BuyUS$14,160Geno GermanoIndividual3,000US$4.72
15 Dec 25BuyUS$6,864Melinda BrownIndividual1,381US$4.97
26 Sep 25BuyUS$13,419Stanley FrankelIndividual2,700US$4.97
22 Sep 25BuyUS$6,846Melinda BrownIndividual1,400US$4.89

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of DTIL?
Owner TypeNumber of SharesOwnership Percentage
Public Companies413,5811.6%
Individual Insiders1,177,8244.56%
Hedge Funds4,205,61116.3%
General Public7,057,81427.4%
Institutions12,947,41750.2%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 132.7%.


Top Shareholders

Top 25 shareholders own 65.97% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.67%
Octagon Capital Advisors LP
2,236,732US$18.3m16.6%1.65%
8.64%
Aberdeen Group Plc
2,230,178US$18.2m4.28%0.01%
7.63%
Empery Asset Management, LP
1,968,879US$16.1m-10.3%18.53%
6.44%
Bleichroeder LP
1,662,500US$13.6m-12.5%2.41%
4.13%
Boothbay Fund Management, LLC
1,066,050US$8.7m0%0.18%
3.86%
Driehaus Capital Management LLC
995,371US$8.1m26.4%0.04%
3.82%
Lynx1 Capital Management LP
985,113US$8.1m-0.89%0.94%
3.53%
Vanguard Capital Management, LLC
910,740US$7.4m0%no data
3.44%
Readout Capital, LP
886,437US$7.3m0%no data
2.32%
Affinity Asset Advisors, LLC
597,946US$4.9m0%0.26%
1.61%
Marshall Wace LLP
415,671US$3.4m486%no data
1.6%
Novartis AG
413,581US$3.4m0%no data
1.53%
Benjamin Weinstein
395,489US$3.2m0%no data
1.19%
Two Sigma Investments, LP
307,790US$2.5m121%no data
1.11%
Geode Capital Management, LLC
287,090US$2.3m27.2%no data
0.94%
Michael Amoroso
243,392US$2.0m111%no data
0.86%
Renaissance Technologies LLC
223,177US$1.8m-31.6%no data
0.77%
BlackRock, Inc.
199,761US$1.6m18.7%no data
0.69%
ArrowMark Colorado Holdings, LLC
179,140US$1.5m0%0.03%
0.6%
Vanguard Fiduciary Trust Company
155,626US$1.3m14.6%no data
0.56%
Corient Private Wealth LLC
143,852US$1.2m1,340%no data
0.54%
Alyeska Investment Group, L.P.
138,825US$1.1m-82.6%no data
0.5%
Jefferson Smith
129,857US$1.1m35.6%no data
0.49%
John Kelly
125,883US$1.0m62.9%no data
0.47%
Morgan Stanley
122,277US$1.0m22.5%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/06 15:35
End of Day Share Price 2026/07/02 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Precision BioSciences, Inc. is covered by 10 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Debjit ChattopadhyayGuggenheim Securities, LLC
Debjit ChattopadhyayH.C. Wainwright & Co.
Patrick TrucchioH.C. Wainwright & Co.